DK0764637T3 - 2-Cyano-3-mercaptocrotonsyreamider - Google Patents
2-Cyano-3-mercaptocrotonsyreamiderInfo
- Publication number
- DK0764637T3 DK0764637T3 DK96114713T DK96114713T DK0764637T3 DK 0764637 T3 DK0764637 T3 DK 0764637T3 DK 96114713 T DK96114713 T DK 96114713T DK 96114713 T DK96114713 T DK 96114713T DK 0764637 T3 DK0764637 T3 DK 0764637T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- substd
- opt
- halo
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Transplantation (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19534649A DE19534649A1 (de) | 1995-09-19 | 1995-09-19 | 2-Cyano-3-mercaptocrotonsäureamide |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0764637T3 true DK0764637T3 (da) | 1999-11-22 |
Family
ID=7772520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96114713T DK0764637T3 (da) | 1995-09-19 | 1996-09-13 | 2-Cyano-3-mercaptocrotonsyreamider |
Country Status (13)
Country | Link |
---|---|
US (1) | US5714514A (da) |
EP (1) | EP0764637B1 (da) |
JP (1) | JPH09132560A (da) |
AT (1) | ATE181730T1 (da) |
AU (1) | AU709499B2 (da) |
CA (1) | CA2185850A1 (da) |
DE (2) | DE19534649A1 (da) |
DK (1) | DK0764637T3 (da) |
ES (1) | ES2135145T3 (da) |
GR (1) | GR3030981T3 (da) |
IL (1) | IL119256A (da) |
MX (1) | MX9604158A (da) |
ZA (1) | ZA967873B (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0123571D0 (en) | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
NZ531765A (en) * | 2001-09-26 | 2006-02-24 | Pharmacia Italia S | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
US8389032B2 (en) * | 2005-05-23 | 2013-03-05 | Kraft Foods Global Brands Llc | Delivery system for active components as part of an edible composition having selected particle size |
-
1995
- 1995-09-19 DE DE19534649A patent/DE19534649A1/de not_active Withdrawn
-
1996
- 1996-09-13 DE DE59602321T patent/DE59602321D1/de not_active Expired - Fee Related
- 1996-09-13 DK DK96114713T patent/DK0764637T3/da active
- 1996-09-13 EP EP96114713A patent/EP0764637B1/de not_active Expired - Lifetime
- 1996-09-13 ES ES96114713T patent/ES2135145T3/es not_active Expired - Lifetime
- 1996-09-13 AT AT96114713T patent/ATE181730T1/de not_active IP Right Cessation
- 1996-09-16 US US08/715,270 patent/US5714514A/en not_active Expired - Lifetime
- 1996-09-17 IL IL11925696A patent/IL119256A/en not_active IP Right Cessation
- 1996-09-17 AU AU65664/96A patent/AU709499B2/en not_active Ceased
- 1996-09-18 CA CA002185850A patent/CA2185850A1/en not_active Abandoned
- 1996-09-18 ZA ZA967873A patent/ZA967873B/xx unknown
- 1996-09-18 MX MX9604158A patent/MX9604158A/es unknown
- 1996-09-18 JP JP8245830A patent/JPH09132560A/ja not_active Abandoned
-
1999
- 1999-08-18 GR GR990402059T patent/GR3030981T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
IL119256A (en) | 2001-07-24 |
IL119256A0 (en) | 1996-12-05 |
DE19534649A1 (de) | 1997-03-20 |
CA2185850A1 (en) | 1997-03-20 |
ES2135145T3 (es) | 1999-10-16 |
ZA967873B (en) | 1997-03-19 |
JPH09132560A (ja) | 1997-05-20 |
MX9604158A (es) | 1997-08-30 |
US5714514A (en) | 1998-02-03 |
AU6566496A (en) | 1997-03-27 |
EP0764637B1 (de) | 1999-06-30 |
GR3030981T3 (en) | 1999-12-31 |
ATE181730T1 (de) | 1999-07-15 |
DE59602321D1 (de) | 1999-08-05 |
EP0764637A2 (de) | 1997-03-26 |
AU709499B2 (en) | 1999-09-02 |
EP0764637A3 (da) | 1997-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59402610D1 (en) | Ortho-substituierte 2-methoxyiminophenylessigsäuremethylamide | |
FI103508B1 (fi) | Menetelmä anti-inflammatorisen aktiivisuuden omaavien 2-substituoitujen tiatsolidinonien, oksatsolidinonien ja imidatsolidinonien 3,5-di-tert.butyyli-4-hydroksifenyylimetyleenijohdannaisten valmistamiseksi | |
DE69524344D1 (de) | Heterocyclisch substituierte Imidazolidine, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zubereitungen | |
UA41358C2 (uk) | Похідні імідазопіридинів, спосіб їх одержання, фармацевтичний склад та спосіб його одержання | |
DE59000151D1 (de) | Verfahren zur bekaempfung von pilzen ausserhalb des menschlichen oder tierischen koerpers. | |
PH24687A (en) | N-1h-tetrazol-5-yl-2-naphthalene carboxamides and their use as antiallergy and antiinflammatory agents | |
DE59602321D1 (de) | 2-Cyano-3-mercaptocrotonsäureamide | |
ITMI912456A1 (it) | Ossa(tia)diazol- e triazol-oni(tioni) ad attivita' acaricida ed insetticida | |
DK0737678T3 (da) | 4-Indolylpiperazinyl-derivater | |
ATE222239T1 (de) | Substituierte-chinolinderivate, verfahren zu ihrer herstellung und ihre verwendung | |
GR3033123T3 (en) | Tricyclic derivatives, their preparation, their use in the preparation of optically active or racemic colchicine, thiocolchicine and analogues or derivatives, and intermediates | |
DE68906122D1 (de) | Verbindungen zur behandlung von harninkontinenz. | |
DE69123757D1 (de) | Epoxysuccinamidsäurederivat | |
EE9600114A (et) | Asendatud 4H-püraanid | |
AU3748697A (en) | 2-cyano-3, 5-dihydroxyhex-2-enecarboxamide derivatives | |
ES8604894A1 (es) | Procedimiento para la obtencion de fluoralcoxifenilsulfonil-guanidinas | |
DE69216015D1 (de) | Heterocyclische Alkoxyacrylsäurederivate mit fungizider Aktivität | |
ES8609254A1 (es) | Un procedimiento para preparar un derivado de piridinodicar-boxilato | |
DE3673797D1 (de) | Triazinderivat, seine herstellung und verwendung. | |
DE69116187D1 (de) | Verwendung eines Dihydropyridins zur Verbesserung der Blutzirkulation des inneren Ohres | |
IT1069996B (it) | Imidazoisoindoldioni sostituiti utili in particolare come diserbanti e realtivo procedimento di produzione |